Skip to content
Inciteful Med

Protecting the Eyes, Joints, and Future (Complications)

Last updated:

Managing Juvenile Idiopathic Arthritis (JIA) requires long-term surveillance to prevent silent complications. Children need regular slit-lamp exams to detect uveitis (eye inflammation) and MRI monitoring for jaw joint arthritis. Preparing teens for adult care ensures consistent disease management.

Key Takeaways

  • • Uveitis is a common, silent eye complication of JIA that requires regular slit-lamp exams by an ophthalmologist.
  • • TMJ (jaw) arthritis can occur without pain and is best detected using a contrast-enhanced MRI to prevent permanent facial changes.
  • • Macrophage Activation Syndrome (MAS) is a medical emergency in Systemic JIA characterized by unremitting fever and sudden laboratory changes.
  • • Transitioning to adult rheumatology care usually begins between ages 12 and 14 to ensure teens can independently manage their health.

Managing Juvenile Idiopathic Arthritis (JIA) is a marathon, not a sprint. While the initial diagnosis is a shock, the long-term goal is to protect your child’s future by staying one step ahead of potential complications [1][2]. This means regular “surveillance” of the eyes and joints, even when your child seems to be doing well [3][4].

Protecting the Eyes: The Uveitis Schedule

Uveitis (internal eye inflammation) is the most common “hidden” complication of JIA [5][3]. Because it is usually painless and does not cause visible redness, it can only be detected with a slit-lamp exam performed by a pediatric ophthalmologist [3][6].

Your child’s screening frequency is based on their risk level, determined by their age at diagnosis and their ANA (Antinuclear Antibody) status [7][8].

  • High Risk: Diagnosed before age 7 AND ANA-positive. These children typically need a slit-lamp exam every 3 months for the first few years [7][9].
  • Moderate Risk: Diagnosed after age 7 OR ANA-negative. These children may only need exams every 6 to 12 months [7][4].
  • Extended Vigilance: Screening is generally recommended for at least 5 to 8 years after the JIA diagnosis, even if the arthritis is in remission [7][10].

Protecting the Jaw: Monitoring the TMJ

The temporomandibular joint (TMJ) or jaw joint is often “silent” when inflamed [11][12]. If left untreated, TMJ arthritis can lead to permanent facial changes, such as a recessed chin (micrognathia) or difficulty opening the mouth [11][1].

  • The Gold Standard: Because a physical exam often misses early TMJ issues, a contrast-enhanced MRI is the most reliable way to detect active inflammation [11][13].
  • Signs to Watch For: Tell your doctor if your child has jaw clicking, pain while chewing, or if they cannot open their mouth as wide as they used to [14][15].

Systemic JIA Emergency: MAS

For children with Systemic JIA (sJIA), there is a rare but very serious complication called Macrophage Activation Syndrome (MAS) [16][17]. This is a medical emergency where the immune system becomes dangerously overactive [18][19]. (Note: This risk primarily applies to the Systemic JIA subtype, not oligoarticular or other forms).

When to go to the Emergency Room:

  • A sudden, high, unremitting fever (different from their usual sJIA fever spikes) [16][19].
  • Extreme fatigue or confusion [16].
  • Easy bruising or unusual bleeding [18][20].
  • Laboratory ‘Red Flags’: Doctors will look for a sudden drop in platelets or an extreme spike in ferritin (a protein that stores iron) [18][21].

Preparing for the Future: Transition of Care

As your child grows into a teenager, the focus shifts toward independence [22][23]. Transition of care is the formal process of moving from a pediatric rheumatologist to an adult specialist [24][25].

  • Timing: Most teams start discussing transition around age 12-14 [24][22].
  • Readiness: Doctors use tools like the TRAQ (Transition Readiness Assessment Questionnaire) to see if your teen can manage their own medications and schedule their own appointments [24][22].
  • The Goal: To ensure there is no “gap” in care when your child becomes an adult, as missing treatments during this phase can lead to major disease flares [25][26].

    By staying vigilant with eye exams, monitoring jaw health, and preparing your teenager for independence, you are ensuring that JIA remains a part of their history—not an obstacle to their future.

Frequently Asked Questions

How often does my child need a slit-lamp eye exam for JIA?
The frequency depends on your child's risk level, age at diagnosis, and ANA status. High-risk children diagnosed before age 7 who are ANA-positive typically need exams every 3 months, while moderate-risk children may only need them every 6 to 12 months.
What are the signs of jaw or TMJ involvement in JIA?
TMJ arthritis in JIA is often silent and painless. However, signs to watch for include jaw clicking, pain while chewing, difficulty opening the mouth wide, or facial changes like a recessed chin.
What are the emergency warning signs of Macrophage Activation Syndrome (MAS)?
MAS is a rare but severe medical emergency where the immune system becomes dangerously overactive. Warning signs include a sudden, high, unremitting fever, extreme fatigue, confusion, and unusual bruising or bleeding.
When should we start planning the transition to an adult rheumatologist?
Most healthcare teams start discussing the transition of care when your child is around 12 to 14 years old. Doctors use readiness tools to evaluate if your teenager can manage their own medications and appointments before officially moving to adult care.

Questions for Your Doctor

  • • Based on my child's age at diagnosis and ANA status, what is the exact frequency of slit-lamp eye exams we should follow?
  • • If my child has a fever spike, what laboratory 'red flags' (like ferritin or platelet levels) should we be monitoring to rule out MAS?
  • • Should we schedule a baseline contrast-enhanced MRI of my child's jaw to check for 'silent' TMJ involvement?
  • • What is our long-term plan for 'transition of care'? Do you use a readiness tool like the TRAQ to help my teenager prepare for adult rheumatology?
  • • At what age do you typically transition patients to an adult specialist, and can you recommend an adult rheumatologist who is experienced with JIA?

Questions for You

  • • Have I scheduled my child's next slit-lamp exam? (Remember, these are necessary even if their vision seems perfect).
  • • Does my child have any difficulty opening their mouth wide, or have I noticed their chin appearing smaller or set back (retrognathia)?
  • • For my teenager: Can they name their medications and explain why they take them without my help?
  • • Does my child have an 'emergency protocol' or contact number for the rheumatology team if they develop a high, unremitting fever?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    A Young Adult Patient with Rheumatoid Disorder Presents for the Evaluation of Limited Mouth Opening.

    Aldosary SN, Tanaka TI

    Dental clinics of North America 2023; (67(4)):633-635 doi:10.1016/j.cden.2023.05.035.

    PMID: 37714612
  2. 2

    [JUVENILE IDIOPATHIC ARTHRITIS].

    Bukovac LT, Perica M

    Reumatizam 2016; (63 Suppl 1()):53-8.

    PMID: 29624302
  3. 3

    Juvenile idiopathic arthritis-associated uveitis.

    Sen ES, Ramanan AV

    Best practice & research. Clinical rheumatology 2017; (31(4)):517-534 doi:10.1016/j.berh.2018.01.002.

    PMID: 29773271
  4. 4

    Diagnosis and treatment of uveitis associated with juvenile idiopathic arthritis.

    Lazăr C, Spîrchez M, Ştefan M, et al.

    Medicine and pharmacy reports 2021; (94(Suppl No 1)):S28-S32 doi:10.15386/mpr-2224.

    PMID: 34527905
  5. 5

    Juvenile idiopathic arthritis and its associated uveitis.

    Maleki A, Patel PD, Foster CS

    Expert review of clinical immunology 2023; (19(9)):1157-1169 doi:10.1080/1744666X.2023.2231154.

    PMID: 37401872
  6. 6

    Juvenile idiopathic arthritis-associated uveitis.

    Sen ES, Ramanan AV

    Clinical immunology (Orlando, Fla.) 2020; (211()):108322 doi:10.1016/j.clim.2019.108322.

    PMID: 31830532
  7. 7

    Prospective Determination of the Incidence and Risk Factors of New-Onset Uveitis in Juvenile Idiopathic Arthritis: The Research in Arthritis in Canadian Children Emphasizing Outcomes Cohort.

    Lee JJY, Duffy CM, Guzman J, et al.

    Arthritis care & research 2019; (71(11)):1436-1443 doi:10.1002/acr.23783.

    PMID: 30320957
  8. 8

    A clinical prediction model for estimating the risk of developing uveitis in patients with juvenile idiopathic arthritis.

    van Straalen JW, Giancane G, Amazrhar Y, et al.

    Rheumatology (Oxford, England) 2021; (60(6)):2896-2905 doi:10.1093/rheumatology/keaa733.

    PMID: 33274366
  9. 9

    Juvenile Idiopathic Arthritis-Associated Chronic Uveitis: Recent Therapeutic Approaches.

    Quartier P

    Journal of clinical medicine 2021; (10(13)) doi:10.3390/jcm10132934.

    PMID: 34208973
  10. 10

    Uveitis in Juvenile Idiopathic Arthritis: 18-Year Outcome in the Population-based Nordic Cohort Study.

    Rypdal V, Glerup M, Songstad NT, et al.

    Ophthalmology 2021; (128(4)):598-608 doi:10.1016/j.ophtha.2020.08.024.

    PMID: 32866542
  11. 11

    MRI of the temporomandibular joint in children with juvenile idiopathic arthritis: protocol and findings.

    Inarejos Clemente EJ, Tolend M, Navallas M, et al.

    Pediatric radiology 2023; (53(8)):1498-1512 doi:10.1007/s00247-023-05616-7.

    PMID: 36944679
  12. 12

    Is early TMJ involvement in children with juvenile idiopathic arthritis clinically detectable? Clinical examination of the TMJ in comparison with contrast enhanced MRI in patients with juvenile idiopathic arthritis.

    Keller H, Müller LM, Markic G, et al.

    Pediatric rheumatology online journal 2015; (13()):56 doi:10.1186/s12969-015-0056-2.

    PMID: 26646650
  13. 13

    MR Imaging of the Temporomandibular Joint in Juvenile Idiopathic Arthritis: Technique and Findings.

    Navallas M, Inarejos EJ, Iglesias E, et al.

    Radiographics : a review publication of the Radiological Society of North America, Inc 2017; (37(2)):595-612 doi:10.1148/rg.2017160078.

    PMID: 28287946
  14. 14

    Mandibular range of motion in children with juvenile idiopathic arthritis with and without clinically established temporomandibular joint involvement and in healthy children; a cross-sectional study.

    de Sonnaville WFC, Speksnijder CM, Zuithoff NPA, et al.

    Pediatric rheumatology online journal 2021; (19(1)):106 doi:10.1186/s12969-021-00583-5.

    PMID: 34217306
  15. 15

    Quantitative analysis of facial asymmetry based on three-dimensional photography: a valuable indicator for asymmetrical temporomandibular joint affection in juvenile idiopathic arthritis patients?

    Bernini JM, Kellenberger CJ, Eichenberger M, et al.

    Pediatric rheumatology online journal 2020; (18(1)):10 doi:10.1186/s12969-020-0401-y.

    PMID: 32005249
  16. 16

    Unexpected macrophage activation syndrome in a healthy young woman: a case report.

    Saviano A, Petrucci M, Tilli P, et al.

    European review for medical and pharmacological sciences 2020; (24(13)):7320-7323 doi:10.26355/eurrev_202007_21893.

    PMID: 32706070
  17. 17

    2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.

    Ravelli A, Minoia F, Davì S, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2016; (68(3)):566-76 doi:10.1002/art.39332.

    PMID: 26314788
  18. 18

    Macrophage Activation Syndrome.

    Sen ES, Clarke SL, Ramanan AV

    Indian journal of pediatrics 2016; (83(3)):248-53 doi:10.1007/s12098-015-1877-1.

    PMID: 26400031
  19. 19

    Allogeneic Hematopoietic Cell Transplant for Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.

    Davidson N, Rangarajan HG, Driest K, et al.

    Case reports in rheumatology 2021; (2021()):9323141 doi:10.1155/2021/9323141.

    PMID: 34123455
  20. 20

    Characterization of Patients with Macrophage Activation Syndrome Secondary to Systemic Juvenile Idiopathic Arthritis.

    Rogowska J, Kubicka J, Grabowska M, et al.

    Clinical rheumatology 2025; (44(5)):2023-2029 doi:10.1007/s10067-025-07420-0.

    PMID: 40146446
  21. 21

    Heterogeneity of macrophage activation syndrome and treatment progression.

    Dong Y, Wang T, Wu H

    Frontiers in immunology 2024; (15()):1389710 doi:10.3389/fimmu.2024.1389710.

    PMID: 38736876
  22. 22

    Transition readiness in adolescents with juvenile idiopathic arthritis and their parents: Our single-center experience.

    Lazarević D, Đorđević S, Novaković D, et al.

    Archives of rheumatology 2022; (37(3)):411-416 doi:10.46497/ArchRheumatol.2022.9219.

    PMID: 36589608
  23. 23

    Assessment of transition readiness in adolescents in Thailand with rheumatic diseases: a cross-sectional study.

    Kittivisuit S, Lerkvaleekul B, Soponkanaporn S, et al.

    Pediatric rheumatology online journal 2021; (19(1)):101 doi:10.1186/s12969-021-00602-5.

    PMID: 34193176
  24. 24

    The readiness of pediatric rheumatology patients and their parents to transition to adult-oriented treatment.

    Sönmez HE, Koç R, Karadağ ŞG, Aktay Ayaz N

    International journal of rheumatic diseases 2021; (24(3)):397-401 doi:10.1111/1756-185X.14050.

    PMID: 33452739
  25. 25

    Patterns and rates of confirmed transfer of care of patients with juvenile idiopathic arthritis at a tertiary paediatric rheumatology centre.

    Tan J, Tiller G, Gowdie P, et al.

    Internal medicine journal 2023; (53(1)):46-50 doi:10.1111/imj.15509.

    PMID: 34498355
  26. 26

    [Juvenile idiopathic arthritis-Diagnosis and management].

    Brück N, Reiser C, Oommen PT, Welzel T

    Zeitschrift fur Rheumatologie 2025; (84(2)):140-151 doi:10.1007/s00393-025-01626-y.

    PMID: 39961862

This page provides educational information about JIA complications and monitoring. It is not a substitute for professional medical advice or routine screening by your child's pediatric rheumatologist and ophthalmologist.

Stay up to date

Get notified when new research about Juvenile idiopathic arthritis is published.

No spam. Unsubscribe anytime.